Microparticle analysis in disorders of hemostasis and thrombosis

Cytometry Part A

Volumn 89, Issue 2, 2016, Pages 111-122

  Mooberry, Micah J ^a   Key, Nigel S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Coagulation; Flow cytometry; Hemostasis; Microparticles; Microvesicles; Thrombosis

Indexed keywords

ANIMAL; BLOOD; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; MEMBRANE MICROPARTICLE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; THROMBOCYTE; THROMBOSIS;

ANIMALS; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; FLOW CYTOMETRY; HEMOSTASIS; HUMANS; THROMBOSIS;

EID: 84958663989     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22647     Document Type: Review

References (176)

1. Chargaff E, West R. The biological significance of the thromboplastic protein of blood. J Biol Chem 1946;166:189-197.
2. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967;13:269-288.
3. Tesse A, Martínez MC, Meziani F, Hugel B, Panaro MA, Mitolo V, Freyssinet JM, Andriantsitohaina R. Origin and biological significance of Shed-membrane microparticles. Endocrine Metab Immune Disord Drug Targets 2006;6:287-294.
4. Zwaal RFA, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005;62:971-988.
5. Thaler J, Ay C, Pabinger I. Clinical significance of circulating microparticles for venous thromboembolism in cancer patients. Hamostaseologie 2012;32:127-131.
6. Jimenez JJ, Jy W, Mauro LM, Soderl C, Horstman LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003;109:175-180.
7. Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004;9:1118-1135.
8. Ahn YS, Jy W, Jimenez JJ, Horstman LL. More on: Cellular microparticles: What are they bad or good for? J Thromb Haemost 2004;2:1215-1216.
9. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009;101:439-451.
10. Connor DE, Exner T, Ma DD, Joseph JE. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein ib. Thromb Haemost 2010;103:1044-1052.
11. Yuana Y, Bertina RM, Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2011;105:396-408.
12. Key NS, Chantrathammachart P, Moody PW, Chang JY. Membrane microparticles in VTE and cancer. Thromb Res 2010;125:S80-S83.
13. Zahra S, Anderson JAM, Stirling D, Ludlam CA. Microparticles, malignancy and thrombosis. Br J Haematol 2011;152:688-700.
14. Thom SR, Yang M, Bhopale VM, Huang S, Milovanova TN. Microparticles initiate decompression-induced neutrophil activation and subsequent vascular injuries. J Appl Physiol 2011;110:340-351.
15. Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 2012;1820:940-948.
16. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009;9:581-593.
17. Théry C, Zitvogel L, Amigorena S. Exosomes: Composition, biogenesis and function. Nat Rev Immunol 2002;2:569-579.
18. Théry C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S. Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001;166:7309-7318.
19. Johnstone RM. Exosomes biological significance: A concise review. Blood Cells Mol Dis 2006;36:315-321.
20. Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS. Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 2006;39:683-690.
21. Berda-Haddad Y, Robert S, Salers P, Zekraoui L, Farnarier C, Dinarello CA, Dignat-George F, Kaplanski G. Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1alpha. Proc Natl Acad Sci USA 2011;108:20684-20689.
22. Schiller M, Bekeredjian-Ding I, Heyder P, Blank N, Ho AD, Lorenz HM. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ 2007;15:183-191.
23. Raposo G, Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 2013;200:373-383.
24. György B, Szabó T, Pásztói M, Pál Z, Misják P, Aradi B, László V, Pállinger É, Pap E, Kittel Á, et al. Membrane vesicles, current state-of-the-art: Emerging role of extracellular vesicles. Cell Mol Life Sci 2011;68:2667-2688.
25. Dvorak HF, Quay SC, Orenstein NS, Dvorak AM, Hahn P, Bitzer AM, Carvalho AC. Tumor shedding and coagulation. Science 1981;212:923-924.
26. Daniel L, Fakhouri F, Joly D, Mouthon L, Nusbaum P, Grunfeld JP, Schifferli J, Guillevin L, Lesavre P, Halbwachs-Mecarelli L. Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int 2006;69:1416-1423.
27. Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol 2007;137:36-48.
28. Flaumenhaft R, Dilks JR, Richardson J, Alden E, Patel-Hett SR, Battinelli E, Klement GL, Sola-Visner M, Italiano JE. Megakaryocyte-derived microparticles: Direct visualization and distinction from platelet-derived microparticles. Blood 2009;113:1112-1121.
29. Morel O, Morel N, Jesel L, Freyssinet JM, Toti F. Microparticles: A critical component in the nexus between inflammation, immunity, and thrombosis. Semin Immunopathol 2011;33:469-486.
30. Freyssinet JM, Toti F, Hugel B, Gidon-Jeangirard C, Kunzelmann C, Martinez MC, Meyer D. Apoptosis in vascular disease. Thromb Haemost 1999;82:727-735.
31. Horstman LL, Jy W, Jimenez JJ, Bidot C, Ahn YS. New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 2004;53:210-230.
32. Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi H, Komiyama Y, Fujimura Y, Ikeda Y, Fukuhara S. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996; 88:3456-3464.
33. Morel O, Jesel L, Freyssinet J-M, Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011;31:15-26.
34. Chang CP, Zhao J, Wiedmer T, Sims PJ. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 1993;268:7171-7178.
35. Lacroix R, Dubois C, Leroyer AS, Sabatier F, Dignat-George F. Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost 2013;11:24-35.
36. Owens AP III, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011;108:1284-1297.
37. Davizon P, Lopez JA. Microparticles and thrombotic disease. Curr Opin Hematol 2009;16:334-341.
38. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007;97:425-434.
39. Key NS, Mackman N. Tissue factor and its measurement in whole blood, plasma, and microparticles. Semin Thromb Hemost 2010;36:865-875.
40. Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2007;27:1687-1693.
41. Camera M, Brambilla M, Toschi V, Tremoli E. Tissue factor expression on platelets is a dynamic event. Blood 2010;116:5076-5077.
42. Bouchard BA, Mann KG, Butenas S. No evidence for tissue factor on platelets. Blood 2010;116:854-855.
43. Van Der Meijden PEJ, Van Schilfgaarde M, Van Oerle R, RennÉ T, Ten Cate H, Spronk HMH. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. J Thromb Haemost 2012;10:1355-1362.
44. van Beers EJ, Schaap MCL, Berckmans RJ, Nieuwl R, Sturk A, van Doormaal FF, Meijers JCM, Biemond BJ. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009;94:1513-1519.
45. Rubin O, Delobel J, Prudent M, Lion N, Kohl K, Tucker EI, Tissot J-D, Angelillo-Scherrer A. Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation. Transfusion 2013;53:1744-1754.
46. Woodruff R, Sullenger B, Becker R. The many faces of the contact pathway and their role in thrombosis. J Thromb Thrombolysis 2011;32:9-20.
47. Gruber A. The role of the contact pathway in thrombus propagation. Thromb Res 2014;133:S45-S47.
48. Kushak RI, Nestoridi E, Lambert J, Selig MK, Ingelfinger JR, Grabowski EF. Detached endothelial cells and microparticles as sources of tissue factor activity. Thromb Res 2005;116:409-419.
49. Steppich B, Mattisek C, Sobczyk D, Kastrati A, Schömig A, Ott I. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost 2005;93:35-39.
50. Koshiar LR, Somajo S, Norstrom E, Dahlback B. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation. PLoS One 2014;9:e104200.
51. Somajo S, Koshiar RL, Norström E, Dahlbäck B. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C. Thromb Res 2014;134:144-152.
52. Tans G, Rosing J, Thomassen M, Heeb M, Zwaal R, Griffin J. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991;77:2641-2648.
53. Lacroix R, Dignat-George F. Microparticles: New protagonists in pericellular and intravascular proteolysis. Semin Thromb Hemost 2013;39:33-39.
54. Lacroix R, Plawinski L, Robert S, Doeuvre L, Sabatier F, Martinez de Lizarrondo S, Mezzapesa A, Anfosso F, Leroyer AS, Poullin P, et al. Leukocyte- and endothelial-derived microparticles: A circulating source for fibrinolysis. Haematologica 2012;97:1864-1872.
55. Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, Celi A, Croce K, Furie BC, Furie B. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003;197:1585-1598.
56. Biro E, Sturk-Maquelin KN, Vogel GM, Meuleman DG, Smit MJ, Hack CE, Sturk A, Nieuwl R. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003;1:2561-2568.
57. Ramacciotti E, Hawley AE, Farris DM, Ballard NE, Wrobleski SK, Myers DD Jr Henke PK, Wakefield TW. Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost 2009;101:748-754.
58. Cooley BC. Murine models of thrombosis. Thromb Res 2012;129:S62-S64.
59. Lacroix R, Robert S, Poncelet P, Dignat-George F. Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost 2010;36:807-818.
60. van der Pol E, Hoekstra AG, Sturk A, Otto C, van Leeuwen TG, Nieuwl R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost 2010;8:2596-2607.
61. Aras O, Shet A, Bach RR, Hysjulien JL, Slungaard A, Hebbel RP, Escolar G, Jilma B, Key NS. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004;103:4545-4553.
62. Connor DE, Exner T, Ma DDF, Joseph JE. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT. Blood Coagul Fibrinolysis 2009;20:558-564.
63. Campello E, Spiezia L, Radu CM, Gavasso S, Woodhams B, Simioni P. Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity. Blood Coagul Fibrinolysis 2014;25:534-537.
64. Haubold K, Rink M, Spath B, Friedrich M, Chun FK-H, Marx G, Amirkhosravi A, Francis JL, Bokemeyer C, Eifrig B, et al. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer. Thromb Haemost 2009;101:1147-1155.
65. Marco A, Brocal C, Marco P. Measurement of procoagulant activity of microparticles in plasma: Feasibility of new functional assays. Thromb Res 2014;134:1363-1364.
66. Yuana Y, Oosterkamp TH, Bahatyrova S, Ashcroft B, Garcia Rodriguez P, Bertina RM, Osanto S. Atomic force microscopy: A novel approach to the detection of nanosized blood microparticles. J Thromb Haemost 2010;8:315-323.
67. Lawrie AS, Albanyan A, Cardigan RA, Mackie IJ, Harrison P. Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sang 2009;96:206-212.
68. Stagnara J, Garnache Ottou F, Angelot F, Mourey G, Seilles E, Biichlé S, Saas P, Racadot E. Correlation between platelet-derived microparticle enumeration by flow cytometry and phospholipid-dependent procoagulant activity in microparticles: The centrifugation step matters!. Thromb Haemost 2012;107:1185-1187.
69. Weiss HJ. Scott syndrome: A disorder of platelet coagulant activity. Semin Hematol 1994;31:312-319.
70. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996;87:1409-1415.
71. Burnouf T, Goubran HA, Chou M-L, Devos D, Radosevic M. Platelet microparticles: Detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev 2014;28:155-166.
72. Franchini M, Mannucci PM. Hemophilia A in the third millennium. Blood Rev 2013;27:179-184.
73. Franchini M. The modern treatment of haemophilia: A narrative review. Blood Transfus 2013;11:178-182.
74. Mobarrez F, Mikovic D, Antovic A, Antovic JP. Is a decrease of microparticles related to improvement of hemostasis after FVIII injection in hemophilia a patients treated on demand? J Thromb Haemost 2013;11:697-703.
75. Federici AB. Clinical diagnosis of von willebrand disease. Haemophilia 2004;10:169-176.
76. Mannucci PM. Treatment of von willebrand's disease. N Engl J Med 2004;351:683-694.
77. Federici AB. The use of desmopressin in von willebrand disease: The experience of the first 30 years (1977-2007). Haemophilia 2008;14:5-14.
78. Colucci G, Stutz M, Rochat S, Conte T, Pavicic M, Reusser M, Giabbani E, Huynh A, Thürlemann C, Keller P, et al. The effect of desmopressin on platelet function: A selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects. Blood 2014;123:1905-1916.
79. Trummer A, Haarmeijer B, Werwitzke S, Wermes C, Ganser A, Budde U, Tiede A. Increased amounts of von willebrand factor are bound to microparticles after infusion of desmopressin. Haemophilia 2013;19:236-241.
80. Tilley RE, Holscher T, Belani R, Nieva J, Mackman N. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res 2008;122:604-609.
81. Toth B, Liebhardt S, Steinig K, Ditsch N, Rank A, Bauerfeind I, Spannagl M, Friese K, Reininger AJ. Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 2008;100:663-669.
82. Thaler J, Ay C, Weinstabl H, Dunkler D, Simanek R, Vormittag R, Freyssinet JM, Zielinski C, Pabinger I. Circulating procoagulant microparticles in cancer patients. Ann Hematol 2011;90:447-453.
83. Laresche C, Pelletier F, Garnache-Ottou F, Lihoreau T, Biichle S, Mourey G, Saas P, Humbert P, Seilles E, Aubin F. Increased levels of circulating microparticles are associated with increased procoagulant activity in patients with cutaneous malignant melanoma. J Invest Dermatol 2014;134:176-182.
84. Toukh M, Siemens DR, Black A, Robb S, Leveridge M, Graham CH, Othman M. Thromboelastography identifies hypercoagulablilty and predicts thromboembolic complications in patients with prostate cancer. Thromb Res 2014;133:88-95.
85. Trappenburg MC, van Schilfgaarde M, Bredewold EO, van Aalderen MC, Spronk HMH, ten Cate H, Leyte A, Terpstra WE. Elevated numbers and altered subsets of procoagulant microparticles in breast cancer patients using endocrine therapy. Thromb Res 2011;127:363-369.
86. Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: A link between cancer and thrombosis? J Thromb Haemost 2007;5:520-527.
87. Tesselaar ME, Romijn FP, van der Linden IK, Bertina RM, Osanto S. Microparticle-associated tissue factor activity in cancer patients with and without thrombosis. J Thromb Haemost 2009;7:1421-1423.
88. Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, Furie B. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009;15:6830-6840.
89. Manly DA, Wang J, Glover SL, Kasthuri R, Liebman HA, Key NS, Mackman N. Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb Res 2010;125:511-512.
90. Campello E, Spiezia L, Radu CM, Bulato C, Castelli M, Gavasso S, Simioni P. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Thromb Res 2011;127:473-477.
91. Sartori MT, Della Puppa A, Ballin A, Saggiorato G, Bernardi D, Padoan A, Scienza R, d'Avella D, Cella G. Prothrombotic state in glioblastoma multiforme: An evaluation of the procoagulant activity of circulating microparticles. J Neurooncol 2011;104:225-231.
92. van Doormaal F, Kleinjan A, Berckmans RJ, Mackman N, Manly D, Kamphuisen PW, Richel DJ, Büller HR, Sturk A, Nieuwl R. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study. Thromb Haemost 2012;108:160-165.
93. Bharthuar A, Khorana AA, Hutson A, Wang J-G, Key NS, Mackman N, Iyer RV. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers. Thromb Res 2013;132:180-184.
94. Sartori MT, Della Puppa A, Ballin A, Campello E, Radu CM, Saggiorato G, d'Avella D, Scienza R, Cella G, Simioni P. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: A potential prothrombotic role. Thromb Haemost 2013;110:378-385.
95. Auwerda JJ, Yuana Y, Osanto S, de Maat MP, Sonneveld P, Bertina RM, Leebeek FW. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma. Thromb Haemost 2011;105:14-20.
96. Thaler J, Ay C, Mackman N, Bertina RM, Kaider A, Marosi C, Key NS Barcel DA, Scheithauer W, Kornek G, et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost 2012;10:1363-1370.
97. Khorana AA, Francis CW, Menzies KE, Wang JG, Hyrien O, Hathcock J, Mackman N, Taubman MB. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 2008;6:1983-1985.
98. Bal L, Ederhy S, Di Angelantonio E, Toti F, Zobairi F, Dufaitre G, Meuleman C, Mallat Z, Boccara F, Tedgui A, et al. Circulating procoagulant microparticles in acute pulmonary embolism: A case-control study. Int J Cardiol 2010;145:321-322.
99. Ye R, Ye C, Huang Y, Liu L, Wang S. Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis. Thromb Res 2012;130:253-258.
100. Chirinos JA, Heresi GA, Velasquez H, Jy W, Jimenez JJ, Ahn E, Horstman LL, Soriano AO, Zambrano JP, Ahn YS. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005;45:1467-1471.
101. Ramacciotti E, Blackburn S, Hawley AE, Vandy F, Ballard-Lipka N, Stabler C, Baker N, Guire KE, Rectenwald JE, Henke PK, et al. Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis. Clin Appl Thromb Hemost 2011;17:425-431.
102. Bucciarelli P, Martinelli I, Artoni A, Passamonti SM, Previtali E, Merati G, Tripodi A, Mannucci PM. Circulating microparticles and risk of venous thromboembolism. Thromb Res 2012;129:591-597.
103. Ay C, Freyssinet J-M, Sailer T, Vormittag R, Pabinger I. Circulating procoagulant microparticles in patients with venous thromboembolism. Thromb Res 2009;123:724-726.
104. Garcia Rodriguez P, Eikenboom HCJ, Tesselaar MET, Huisman MV, Nijkeuter M, Osanto S, Bertina RM. Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism. Thromb Res 2010;126:345-349.
105. Steppich BA, Hassenpflug M, Braun SL, Schomig K, von Beckerath O, von Beckerath N, Eckstein HH, Ott I. Circulating tissue factor and microparticles are not increased in patients with deep vein thrombosis. Vasa 2011;40:117-122.
106. Rectenwald JE, Myers DD Jr, Hawley AE, Longo C, Henke PK, Guire KE, Schmaier AH, Wakefield TW. Ddimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost 2005;94:1312-1317.
107. Flores-Nascimento MC, Beltrame MP, De Paula EV, Montalvão SL, Pereira FG, Orsi FLA, Lorand-Metze I, Annichino-Bizzacchi JM. Microparticles in deep venous thrombosis, antiphospholipid syndrome and factor V leiden. Platelets 2009;20:367-375.
108. Shah MD, Bergeron AL, Dong J-F, López JA. Flow cytometric measurement of microparticles: Pitfalls and protocol modifications. Platelets 2008;19:365-372.
109. Kim HK, Song KS, Lee ES, Lee YJ, Park YS, Lee KR, Lee SN. Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: Pre-analytic and analytic considerations. Blood Coagul Fibrinolysis 2002;13:393-397.
110. György B, Pálóczi K, Kovács A, Barabás E, Beko G, Várnai K, Pállinger É, Szabó-Taylor K, Szabó TG, Kiss AA, et al. Improved circulating microparticle analysis in acid-citrate dextrose (ACD) anticoagulant tube. Thromb Res 2014;133:285-292.
111. Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, Dignat-George F. Impact of pre-analytical parameters on the measurement of circulating microparticles: Toward standardization of protocol. J Thromb Haemost 2012;10:437-446.
112. Vidal C, Spaulding C, Picard F, Schaison F, Melle J, Weber S, Fontenay-Roupie M. Flow cytometry detection of platelet procoagulant activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation. Thromb Haemost 2001;86:784-790.
113. Enjeti AK, Lincz LF, Seldon M. Detection and measurement of microparticles: An evolving research tool for vascular biology. Semin Thromb Hemost 2007;33:771-779.
114. Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, Nieuwl R, Brooks SA, Ferry B. Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay. Thromb Res 2011;127:370-377.
115. van der Heyde HC, Gramaglia I, Combes V, George TC, Grau GE. Flow cytometric analysis of microparticles. Methods Mol Biol 2011;699:337-354.
116. Iversen LV, Ostergaard O, Nielsen CT, Jacobsen S, Heegaard NH. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer. J Immunol Methods 2013;388:49-59.
117. Mobarrez F, Antovic J, Egberg N, Hansson M, Jörneskog G, Hultenby K, Wallén H. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res 2010;125:e110-e116.
118. Dey-Hazra E, Hertel B, Kirsch T, Woywodt A, Lovric S, Haller H, Haubitz M, Erdbruegger U. Detection of circulating microparticles by flow cytometry: Influence of centrifugation, filtration of buffer, and freezing. Vasc Health Risk Manag 2010;6:1125-1133.
119. Shantsila E, Montoro-García S, Gallego P, Lip GYH. Circulating microparticles: Challenges and perspectives of flow cytometric assessment. Thromb Haemost 2014;111:1009-1014.
120. Shapiro HM. Practical Flow Cytometry, 4th ed. New York: Wiley-Liss; 2003. pp 4-5.
121. Zwicker JI, Trenor CC III, Furie BC, Furie B. Tissue factor-bearing microparticles and thrombus formation. Arterioscler Thromb Vasc Biol 2011;31:728-733.
122. Chandler WL, Yeung W, Tait JF. A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer. J Thromb Haemost 2011;9:1216-1224.
123. Mullier F, Bailly N, Chatelain C, Dogne JM, Chatelain B. More on: Calibration for the measurement of microparticles: Needs, interests, and limitations of calibrated polystyrene beads for flow cytometry-based quantification of biological microparticles. J Thromb Haemost 2011;9:1679-1681; author reply 81-82.
124. Robert S, Poncelet P, Lacroix R, Raoult D, Dignat-George F. More on: Calibration for the measurement of microparticles: Value of calibrated polystyrene beads for flow cytometry-based sizing of biological microparticles. J Thromb Haemost 2011;9:1676-1678. author reply 81-82.
125. Chandler WL, Yeung W, Tait JF. More on: Calibration for the measurement of microparticles: The authors respond. J Thromb Haemostasis 2011;9:1681-1682.
126. O'Gorman MR, Thomas J. Isotype controls-Time to let go? Cytometry 1999;38:78-80.
127. Hulspas R, O'Gorman MR, Wood BL, Gratama JW, Sutherl DR. Considerations for the control of background fluorescence in clinical flow cytometry. Cytometry B Clin Cytom 2009;76B:355-364.
128. Keeney M, Gratama JW, Chin-Yee IH, Sutherl DR. Isotype controls in the analysis of lymphocytes and CD34+ stem and progenitor cells by flow cytometry-Time to let go? Cytometry 1998;34:280-283.
129. Maecker HT, Trotter J. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 2006;69A:1037-1042.
130. Trummer A, De Rop C, Tiede A, Ganser A, Eisert R. Isotype controls in phenotyping and quantification of microparticles: A major source of error and how to evade it. Thromb Res 2008;122:691-700.
131. György B, Módos K, Pállinger É, Pálóczi K, Pásztói M, Misják P, Deli MA, Sipos Á, Szalai A, Voszka I, et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood 2011;117:e39-e48.
132. Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A 2010;77A:502-514.
133. Gelderman MP, Simak J. Flow Cytometric Analysis of Cell Membrane Microparticles. Functional Proteomics: Methods and Protocols. Clifton, NJ: Springer; 2008. pp 79-93.
134. Aass HC, Ovstebo R, Troseid AM, Kierulf P, Berg JP, Henriksson CE. Fluorescent particles in the antibody solution result in false TF- and CD14-positive microparticles in flow cytometric analysis. Cytometry A 2011;79A:990-999.
135. van der Pol E, van Gemert MJ, Sturk A, Nieuwl R, van Leeuwen TG. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost 2012;10:919-930.
136. Harrison P, Gardiner C. Invisible vesicles swarm within the iceberg. J Thromb Haemostasis 2012;10:916-918.
137. Erdbrügger U, Rudy CK, Etter EM, Dryden KA, Yeager M, Klibanov AL, Lannigan J. Imaging flow cytometry elucidates limitations of microparticle analysis by conventional flow cytometry. Cytometry A 2014;85A:756-770.
138. Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A, Sampol J, Dignat-George F. Standardization of platelet-derived microparticle counting using calibrated beads and a cytomics FC500 routine flow cytometer: A first step toward multicenter studies? J Thromb Haemost 2009;7:190-197.
139. Lacroix R, Robert S, Poncelet P, Kasthuri RS, Key NS, Dignat-George F. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: Results of the international society on thrombosis and haemostasis SSC collaborative workshop. J Thromb Haemost 2010;8:2571-2574.
140. Lacroix R, Judicone C, Mooberry M, Boucekine M, Key NS, Dignat-George F. Standardization of pre-analytical variables in plasma microparticle determination: Results of the international society on thrombosis and haemostasis SSC collaborative workshop. J Thromb Haemost 2013;11:1190-1193.
141. Tantawy AAG, Adly AAM, Ismail EAR, Habeeb NM, Farouk A. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications. Platelets 2013;24:605-614.
142. Simak J, Holada K, Risitano AM, Zivny JH, Young NS, Vostal JG. Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2004;125:804-813.
143. Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, Koopmeiners L, Key NS, Hebbel RP. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003;102:2678-2683.
144. Zwicker JI. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thromb Res 2010;125 (Supp 2):S89-S91.
145. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Ahn YS. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: Findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol 2001;112:81-90.
146. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Soderl C, Ahn YS. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von willebrand factor and markers of endothelial activation. Br J Haematol 2003;123:896-902.
147. Vikerfors A, Mobarrez F, Bremme K, Holmström M, Ågren A, Eelde A, Bruzelius M, Antovic A, Wallén H, Svenungsson E. Studies of microparticles in patients with the antiphospholipid syndrome (APS). Lupus 2012;21:802-805.
148. Dignat-George F, Camoin-Jau L, Sabatier F, Arnoux D, Anfosso F, Bardin N, Veit V, Combes V, Gentile S, Moal V, et al. Endothelial microparticles: A potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost 2004;91:667-673.
149. Jy W, Tiede M, Bidot CJ, Horstman LL, Jimenez JJ, Chirinos J, Ahn YS. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Thromb Res 2007;121:319-325.
150. Joop K, Berckmans RJ, Nieuwl R, Berkhout J, Romijn FP, Hack CE, Sturk A. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001;85:810-820.
151. Delabranche X, Boisrame-Helms J, Asfar P, Berger A, Mootien Y, Lavigne T, Grunebaum L, Lanza F, Gachet C, Freyssinet JM, et al. Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy. Intensive Care Med 2013;39:1695-1703.
152. Tokés-Füzesi M, Woth G, Ernyey B, Vermes I, Mühl D, Bogár L, Kovács GL. Microparticles and acute renal dysfunction in septic patients. J Crit Care 2013;28:141-147.
153. Nieuwl R, Berckmans RJ, McGregor S, Böing AN, Th M, Romijn FPH, Westendorp RGJ, Hack CE, Sturk A. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000;95:930-935.
154. Tan X, Shi J, Fu Y, Gao C, Yang X, Li J, Wang W, Hou J, Li H, Zhou J. Role of erythrocytes and platelets in the hypercoagulable status in polycythemia vera through phosphatidylserine exposure and microparticle generation. Thromb Haemost 2013;109:1025-1032.
155. Trappenburg MC, van Schilfgaarde M, Marchetti M, Spronk HM, Cate Ht Leyte A, Terpstra WE, Falanga A. Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia. Haematologica 2009;94:911-918.
156. Marchetti M, Tartari CJ, Russo L, Panova-Noeva M, Leuzzi A, Rambaldi A, Finazzi G, Woodhams B, Falanga A. Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia. Am J Hematol. 2014; 89:68-73.
157. Duchemin J, Ugo V, Ianotto J-C, Lecucq L, Mercier B, Abgrall J-F. Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms. Thromb Res 2010;126:238-242.
158. Palkovits J, Novacek G, Kollars M, Hron G, Osterode W, Quehenberger P, Kyrle PA, Vogelsang H, Reinisch W, Papay P, et al. Tissue factor exposing microparticles in inflammatory bowel disease. J Crohns Colitis 2013;7:222-229.
159. Deutschmann A, Schlagenhauf A, Leschnik B, Hoffmann KM, Hauer A, Muntean W. Increased procoagulant function of microparticles in pediatric inflammatory bowel disease: Role in increased thrombin generation. J Pediatr Gastroenterol Nutr 2013;56:401-407.
160. Andoh A, Tsujikawa T, Hata K, Araki Y, Kitoh K, Sasaki M, Yoshida T, Fujiyama Y. Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease. Am J Gastroenterol 2005;100:2042-2048.
161. Gao C, Xie R, Yu C, Wang Q, Shi F, Yao C, Xie R, Zhou J, Gilbert GE, Shi J. Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome. Thromb Haemost 2012;107:681-689.
162. Hugel B, Socié G, Vu T, Toti F, Gluckman E, Freyssinet J-M, Scrobohaci M-L. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999;93:3451-3456.
163. Kambas K, Chrysanthopoulou A, Vassilopoulos D, Apostolidou E, Skendros P, Girod A, Arelaki S, Froudarakis M, Nakopoulou L, Giatromanolaki A, et al. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Ann Rheum Dis 2014;73:1854-1863.
164. Eleftheriou D, Hong Y, Klein NJ, Brogan PA. Thromboembolic disease in systemic vasculitis is associated with enhanced microparticle-mediated thrombin generation. J Thromb Haemost 2011;9:1864-1867.
165. Bretelle F, Sabatier F, Desprez D, Camoin L, Grunebaum L, Combes V, D'Ercole C, Dignat-George F. Circulating microparticles: A marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost 2003;89:486-492.
166. Marques FK, Campos FMF, Filho OAM, Carvalho AT, Dusse LMS, Gomes KB. Circulating microparticles in severe preeclampsia. Clin Chim Acta 2012;414:253-258.
167. Lok CA, Jebbink J, Nieuwl R, Faas MM, Boer K, Sturk A, Van Der Post JA. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am J Reprod Immunol 2009;61:346-359.
168. Lok CA, Van Der Post JA, Sargent IL, Hau CM, Sturk A, Boer K, Nieuwl R. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy 2008;27:344-360.
169. Pereira J, Alfaro G, Goycoolea M, Quiroga T, Ocqueteau M, Massardo L, Perez C, Saez C, Panes O, Matus V, et al. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost 2006;95:94-99.
170. Nielsen CT, Ostergaard O, Johnsen C, Jacobsen S, Heegaard NH. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum 2011;63:3067-3077.
171. Sellam J, Proulle V, Jungel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, et al. Increased levels of circulating microparticles in primary sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 2009;11:R156.
172. Campello E, Spiezia L, Radu CM, Bon M, Gavasso S, Zerbinati P, Woodhams B, Tormene D, Prandoni P, Simioni P. Circulating microparticles in carriers of factor V leiden with and without a history of venous thrombosis. Thromb Haemost 2012;108:633-639.
173. Enjeti AK, Lincz LF, Scorgie FE, Seldon M. Circulating microparticles are elevated in carriers of factor V leiden. Thromb Res 2010;126:250-253.
174. Park MS, Owen BAL, Ballinger BA, Sarr MG, Schiller HJ, Zietlow SP, Jenkins DH, Ereth MH, Owen WG, Heit JA. Quantification of hypercoagulable state after blunt trauma: Microparticle and thrombin generation are increased relative to injury severity, while standard markers are not. Surgery 2012;151:831-836.
175. Morel N, Morel O, Petit L, Hugel B, Cochard JF, Freyssinet JM, Sztark F, Dabadie P. Generation of procoagulant microparticles in cerebrospinal fluid and peripheral blood after traumatic brain injury. J Trauma 2008;64:698-704.
176. Ogura H, Kawasaki T, Tanaka H, Koh T, Tanaka R, Ozeki Y, Hosotsubo H, Kuwagata Y, Shimazu T, Sugimoto H. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma 2001;50:801-809.